Cargando…

Lymphoid Enhancer Factor 1 Contributes to Hepatocellular Carcinoma Progression Through Transcriptional Regulation of Epithelial‐Mesenchymal Transition Regulators and Stemness Genes

Lymphoid enhancer factor 1 (LEF1) activity is associated with progression of several types of cancers. The role of LEF1 in progression of hepatocellular carcinoma (HCC) remains poorly known. We investigated LEF1 expression in HCC and its interactions with epithelial‐mesenchymal transition (EMT) regu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chih‐Li, Tsai, Yu‐Shuen, Huang, Yen‐Hua, Liang, Yuh‐Jin, Sun, Ya‐Yun, Su, Chien‐Wei, Chau, Gar‐Yang, Yeh, Yi‐Chen, Chang, Yung‐Sheng, Hu, Jui‐Ting, Wu, Jaw‐Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211324/ https://www.ncbi.nlm.nih.gov/pubmed/30411085 http://dx.doi.org/10.1002/hep4.1229

Ejemplares similares

Upregulation of USP22 and ABCC1 during Sorafenib Treatment of Hepatocellular Carcinoma Contribute to Development of Resistance
por: Chang, Yung-Sheng, et al.
Publicado: (2022)

Forfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCC
por: Wang, Hsei-Wei, et al.
Publicado: (2013)

Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition
por: Wang, Tong-Hong, et al.
Publicado: (2016)

High Expression of MicroRNA-196a is Associated with Progression of Hepatocellular Carcinoma in Younger Patients
por: Wang, Shen-Yung, et al.
Publicado: (2019)

Leukocyte cell-derived chemotaxin 2 regulates epithelial-mesenchymal transition and cancer stemness in hepatocellular carcinoma
por: Chu, Tian-Huei, et al.
Publicado: (2022)

A comparison of prognoses between surgical resection and radiofrequency ablation therapy for patients with hepatocellular carcinoma and esophagogastric varices
por: Wei, Cheng-Yi, et al.
Publicado: (2020)

Surgical resection could provide better outcomes for patients with hepatocellular carcinoma and tumor rupture
por: Lee, Chun-Yang, et al.
Publicado: (2022)

Comparison of prognosis between surgical resection and transarterial chemoembolization for patients with solitary huge hepatocellular carcinoma
por: Wei, Cheng-Yi, et al.
Publicado: (2020)

MicroRNA-224 down-regulates Glycine N-methyltransferase gene expression in Hepatocellular Carcinoma
por: Hung, Jung-Hsien, et al.
Publicado: (2018)

The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy
por: Su, Chien-Wei, et al.
Publicado: (2013)

Synchronous hepatocellular carcinoma and lymphoepithelioma-like carcinoma arising from 2 different sites of the liver: A case report
por: Shih, En-Jie, et al.
Publicado: (2018)

Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition
por: Wang, Tong-Hong, et al.
Publicado: (2015)

Therapeutic Ultrasound Halts Progression of Chronic Kidney Disease In Vivo via the Regulation of Markers Associated with Renal Epithelial–Mesenchymal Transition and Senescence
por: Lin, Chen-Yu, et al.
Publicado: (2022)

Statin inhibits large hepatitis delta antigen-Smad3 -twist-mediated epithelial-to-mesenchymal transition and hepatitis D virus secretion
por: Liang, Yuh-Jin, et al.
Publicado: (2020)

Up-regulation of RNF187 induces hepatocellular carcinoma cell epithelial to mesenchymal transitions
por: Yu, Song-Lin, et al.
Publicado: (2017)

ARK5 promotes invasion and migration in hepatocellular carcinoma cells by regulating epithelial-mesenchymal transition
por: Ye, Zhiyu, et al.
Publicado: (2018)

Dioscorea alata Attenuates Renal Interstitial Cellular Fibrosis by Regulating Smad- and Epithelial-Mesenchymal Transition Signaling Pathways
por: Liu, Shu-Fen, et al.
Publicado: (2012)

A Comparison of Clinical Manifestations and Prognoses Between Patients with Hepatocellular Carcinoma and Child–Pugh Scores of 5 or 6
por: Hung, Hung-Hsu, et al.
Publicado: (2014)

Krüppel-Like Factor 4, a Tumor Suppressor in Hepatocellular Carcinoma Cells Reverts Epithelial Mesenchymal Transition by Suppressing Slug Expression
por: Lin, Ze-Shiang, et al.
Publicado: (2012)

HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3
por: Chen, Jhen-Yu, et al.
Publicado: (2015)

Pinin Induces Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma by Regulating m6A Modification
por: Qiao, Kailiang, et al.
Publicado: (2021)

Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure
por: Lee, I-Cheng, et al.
Publicado: (2017)

TAZ regulates cell proliferation and epithelial–mesenchymal transition of human hepatocellular carcinoma
por: Xiao, Heng, et al.
Publicado: (2015)

PTIP promotes recurrence and metastasis of hepatocellular carcinoma by regulating epithelial-mesenchymal transition
por: Leng, Shusheng, et al.
Publicado: (2017)

Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin
por: Dong, Qiongzhu, et al.
Publicado: (2016)

Down-Regulated CMTM2 Promotes Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
por: Zhang, Shidong, et al.
Publicado: (2020)

CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial-mesenchymal transition
por: Yang, Gang, et al.
Publicado: (2021)

Correction: Krüppel-Like Factor 4, a Tumor Suppressor in Hepatocellular Carcinoma Cells Reverts Epithelial Mesenchymal Transition by Suppressing Slug Expression
por: Lin, Ze-Shiang, et al.
Publicado: (2013)

Correction: Krüppel-like Factor 4, a Tumor Suppressor in Hepatocellular Carcinoma Cells Reverts Epithelial Mesenchymal Transition by Suppressing Slug Expression
por: Lin, Ze-Shiang, et al.
Publicado: (2016)

Montelukast Increased IL-25, IL-33, and TSLP via Epigenetic Regulation in Airway Epithelial Cells
por: Tsai, Mei-Lan, et al.
Publicado: (2023)

Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial–mesenchymal transition in non-small cell lung cancer cells
por: Li, Ching-Hao, et al.
Publicado: (2016)

Epithelial to Mesenchymal Transition and Cell Biology of Molecular Regulation in Endometrial Carcinogenesis
por: Chiu, Hsiao-Chen, et al.
Publicado: (2019)

Molecular events associated with epithelial to mesenchymal transition of nasopharyngeal carcinoma cells in the absence of Epstein-Barr virus genome
por: Lin, Jung-Chung, et al.
Publicado: (2009)

Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognostic factor in hepatitis C virus-related hepatocellular carcinoma
por: Lin, Ching-Chih, et al.
Publicado: (2021)

FOXC1 Contributes To Microvascular Invasion In Primary Hepatocellular Carcinoma Via Regulating Epithelial-Mesenchymal Transition
por: Xu, Zhi-Yuan, et al.
Publicado: (2012)

TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator
por: Tsai, Ya-Ping, et al.
Publicado: (2014)

Regulation of the Epithelial to Mesenchymal Transition in Osteosarcoma
por: Hinton, Kristin, et al.
Publicado: (2023)

KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal Transition
por: Hu, Bo, et al.
Publicado: (2019)

Matrine inhibits the invasive and migratory properties of human hepatocellular carcinoma by regulating epithelial-mesenchymal transition
por: Wang, Yuwen, et al.
Publicado: (2018)

SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells
por: Gao, Tong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hi8k228angsegrh9j80nc6mc7v